|
|
|
|
 |
Contents |
 |
|
|
|
|
|
|
|
|
|
183 a.a.
|
 |
|
|
|
|
|
|
|
195 a.a.
|
 |
|
|
|
|
|
|
|
169 a.a.
|
 |
|
|
|
|
|
|
* Residue conservation analysis
|
|
|
|
|
PDB id:
|
 |
|
 |
| Name: |
 |
Hormone/growth factor/hormone receptor
|
 |
|
Title:
|
 |
Crystal structure of the ternary complex between ovine placental lactogen and the extracellular domain of the rat prolactin receptor
|
|
Structure:
|
 |
Placental lactogen. Chain: a. Engineered: yes. Prolactin receptor. Chain: b, c. Fragment: extracellular domain. N-terminal fibronectin type iii domains. Engineered: yes
|
|
Source:
|
 |
Ovis aries. Sheep. Organism_taxid: 9940. Expressed in: escherichia coli. Expression_system_taxid: 562. Rattus norvegicus. Norway rat. Organism_taxid: 10116. Organ: liver.
|
|
Biol. unit:
|
 |
Hexamer (from
)
|
|
Resolution:
|
 |
|
2.30Å
|
R-factor:
|
0.225
|
R-free:
|
0.287
|
|
|
Authors:
|
 |
P.A.Elkins,H.W.Christinger,Y.Sandowski,E.Sakal,A.Gertler,A.M.De Vos, A.A.Kossiakoff
|
Key ref:
|
 |
P.A.Elkins
et al.
(2000).
Ternary complex between placental lactogen and the extracellular domain of the prolactin receptor.
Nat Struct Biol,
7,
808-815.
PubMed id:
DOI:
|
 |
|
Date:
|
 |
|
21-Jun-00
|
Release date:
|
04-Jul-00
|
|
|
|
|
|
PROCHECK
|
|
|
|
|
Headers
|
 |
|
|
References
|
|
|
|
|
|
|
P16038
(CSH_SHEEP) -
Chorionic somatomammotropin hormone from Ovis aries
|
|
|
|
Seq: Struc:
|
 |
 |
 |
236 a.a.
183 a.a.
|
|
|
|
|
|
|
|
|
 |
 |
|
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
|
|
|
| |
|
DOI no:
|
Nat Struct Biol
7:808-815
(2000)
|
|
PubMed id:
|
|
|
|
|
| |
|
Ternary complex between placental lactogen and the extracellular domain of the prolactin receptor.
|
|
P.A.Elkins,
H.W.Christinger,
Y.Sandowski,
E.Sakal,
A.Gertler,
A.M.de Vos,
A.A.Kossiakoff.
|
|
|
|
| |
ABSTRACT
|
|
|
| |
|
The structure of the ternary complex between ovine placental lactogen (oPL) and
the extracellular domain (ECD) of the rat prolactin receptor (rPRLR) reveals
that two rPRLR ECDs bind to opposite sides of oPL with pseudo two-fold symmetry.
The two oPL receptor binding sites differ significantly in their topography and
electrostatic character. These binding interfaces also involve different
hydrogen bonding and hydrophobic packing patterns compared to the structurally
related human growth hormone (hGH)-receptor complexes. Additionally, the
receptor-receptor interactions are different from those of the hGH-receptor
complex. The conformational adaptability of prolactin and growth hormone
receptors is evidenced by the changes in local conformations of the receptor
binding loops and more global changes induced by shifts in the angular
relationships between the N- and C-terminal domains, which allow the receptor to
bind to the two topographically distinct sites of oPL.
|
|
|
|
|
| |
Selected figure(s)
|
|
|
| |
 |
 |
|
 |
|
 |
Figure 1.
Figure 1. The oPL -rPRLR[2] ternary complex. The binding
loops on R1 and R2 are numbered. Loops L1 -L3 are in the
N-terminal domain of the receptor, L4 is in the linker region
between the domains and L5 and L6 are in the C-terminal domain.
In the R2 C-terminal domain, L5 and L6 are disordered. The -sheet
cores of the domains of R1 and R2 superimpose with an r.m.s.
deviation for the N-terminal domain of 0.8 Å for 53 C atoms;
for the C-terminal domain the r.m.s. deviation is 0.5 Å for 63 C
atoms.
|
 |
Figure 2.
Figure 2. Ribbon diagram of oPL (left) and hGH (right).
Helices 1 -4 are labeled on the oPL molecule, and the crossover
loop between helices 1 and 2 and the mini-helix are labeled on
the hGH molecule. The N-terminal extension on oPL is shown in
yellow. In the oPL model, residues 46 -47, 96 -100 and 190 -191
are omitted due to disorder.
|
 |
|
|
|
| |
The above figures are
reprinted
by permission from Macmillan Publishers Ltd:
Nat Struct Biol
(2000,
7,
808-815)
copyright 2000.
|
|
| |
Figures were
selected
by an automated process.
|
|
|
|
|
 |
 |
|
 |
 |
 |
 |
 |
 |
 |
 |
 |
|
Literature references that cite this PDB file's key reference
|
|
 |
| |
PubMed id
|
 |
Reference
|
 |
|
|
|
 |
E.M.Jacobson,
E.R.Hugo,
T.R.Tuttle,
R.Papoian,
and
N.Ben-Jonathan
(2010).
Unexploited therapies in breast and prostate cancer: blockade of the prolactin receptor.
|
| |
Trends Endocrinol Metab,
21,
691-698.
|
 |
|
|
|
|
 |
I.Broutin,
J.B.Jomain,
E.Tallet,
J.van Agthoven,
B.Raynal,
S.Hoos,
B.B.Kragelund,
P.A.Kelly,
A.Ducruix,
P.England,
and
V.Goffin
(2010).
Crystal structure of an affinity-matured prolactin complexed to its dimerized receptor reveals the topology of hormone binding site 2.
|
| |
J Biol Chem,
285,
8422-8433.
|
 |
|
PDB code:
|
 |
|
|
|
|
|
 |
Y.L.Xie,
S.A.Hassan,
A.M.Qazi,
C.H.Tsai-Morris,
and
M.L.Dufau
(2009).
Intramolecular disulfide bonds of the prolactin receptor short form are required for its inhibitory action on the function of the long form of the receptor.
|
| |
Mol Cell Biol,
29,
2546-2555.
|
 |
|
|
|
|
 |
C.V.Clevenger,
J.Zheng,
E.M.Jablonski,
T.L.Galbaugh,
and
F.Fang
(2008).
From bench to bedside: future potential for the translation of prolactin inhibitors as breast cancer therapeutics.
|
| |
J Mammary Gland Biol Neoplasia,
13,
147-156.
|
 |
|
|
|
|
 |
D.Tan,
K.T.Huang,
E.Ueda,
and
A.M.Walker
(2008).
S2 deletion variants of human PRL receptors demonstrate that extracellular domain conformation can alter conformation of the intracellular signaling domain.
|
| |
Biochemistry,
47,
479-489.
|
 |
|
|
|
|
 |
E.Tallet,
V.Rouet,
J.B.Jomain,
P.A.Kelly,
S.Bernichtein,
and
V.Goffin
(2008).
Rational design of competitive prolactin/growth hormone receptor antagonists.
|
| |
J Mammary Gland Biol Neoplasia,
13,
105-117.
|
 |
|
|
|
|
 |
L.A.Svensson,
K.Bondensgaard,
L.Nørskov-Lauritsen,
L.Christensen,
P.Becker,
M.D.Andersen,
M.J.Maltesen,
K.D.Rand,
and
J.Breinholt
(2008).
Crystal structure of a prolactin receptor antagonist bound to the extracellular domain of the prolactin receptor.
|
| |
J Biol Chem,
283,
19085-19094.
|
 |
|
PDB code:
|
 |
|
|
|
|
|
 |
M.Simonović,
and
T.A.Steitz
(2008).
Cross-crystal averaging reveals that the structure of the peptidyl-transferase center is the same in the 70S ribosome and the 50S subunit.
|
| |
Proc Natl Acad Sci U S A,
105,
500-505.
|
 |
|
|
|
|
 |
R.L.Bogorad,
C.Courtillot,
C.Mestayer,
S.Bernichtein,
L.Harutyunyan,
J.B.Jomain,
A.Bachelot,
F.Kuttenn,
P.A.Kelly,
V.Goffin,
P.Touraine,
A.Bachelot,
B.Belaroussi,
J.Bensimhon,
J.Berdah,
M.J.Blin,
A.Boudinet,
B.Brethon,
C.Bricaire,
J.Caby,
G.Caillaud,
J.C.Carel,
N.Chabbert-Buffet,
H.Charitanski,
C.Chretien,
K.Clough,
C.Courtillot,
G.Delattre,
I.Denys,
K.Desthieux-Ngo,
M.Detoeuf,
C.Dhainault,
C.Duflos,
O.Fiori,
C.Genestie,
G.Gibaud,
A.Gompel,
C.Gracia,
A.Grimard,
C.Hofman,
H.Hofman,
F.Kuttenn,
F.Laki,
C.Lanty,
J.P.Lefranc,
M.A.Le Frere-Belda,
D.Leger,
F.Martinez,
A.May,
L.Meng,
C.Nos,
D.Pelletier,
A.Perrin,
G.Plu-Bureau,
B.Raccah-Tebbeca,
J.C.Saiovici,
R.Salmon,
M.Sibout,
B.Sigal-Zafrani,
J.C.Thalabard,
E.Thibaud,
A.Thoury,
P.Touraine,
K.B.Triana-Rabi,
S.Uzan,
J.Viriot,
and
S.Yacoub
(2008).
Identification of a gain-of-function mutation of the prolactin receptor in women with benign breast tumors.
|
| |
Proc Natl Acad Sci U S A,
105,
14533-14538.
|
 |
|
|
|
|
 |
J.B.Jomain,
E.Tallet,
I.Broutin,
S.Hoos,
J.van Agthoven,
A.Ducruix,
P.A.Kelly,
B.B.Kragelund,
P.England,
and
V.Goffin
(2007).
Structural and thermodynamic bases for the design of pure prolactin receptor antagonists: X-ray structure of Del1-9-G129R-hPRL.
|
| |
J Biol Chem,
282,
33118-33131.
|
 |
|
PDB code:
|
 |
|
|
|
|
|
 |
S.Pletnev,
E.Magracheva,
A.Wlodawer,
and
A.Zdanov
(2005).
A model of the ternary complex of interleukin-10 with its soluble receptors.
|
| |
BMC Struct Biol,
5,
10.
|
 |
|
|
|
|
 |
T.Ishino,
C.Urbina,
M.Bhattacharya,
D.Panarello,
and
I.Chaiken
(2005).
Receptor epitope usage by an interleukin-5 mimetic peptide.
|
| |
J Biol Chem,
280,
22951-22961.
|
 |
|
|
|
|
 |
F.Peelman,
K.Van Beneden,
L.Zabeau,
H.Iserentant,
P.Ulrichts,
D.Defeau,
A.Verhee,
D.Catteeuw,
D.Elewaut,
and
J.Tavernier
(2004).
Mapping of the leptin binding sites and design of a leptin antagonist.
|
| |
J Biol Chem,
279,
41038-41046.
|
 |
|
|
|
|
 |
T.Ishino,
G.Pasut,
J.Scibek,
and
I.Chaiken
(2004).
Kinetic interaction analysis of human interleukin 5 receptor alpha mutants reveals a unique binding topology and charge distribution for cytokine recognition.
|
| |
J Biol Chem,
279,
9547-9556.
|
 |
|
|
|
|
 |
A.De Léan,
N.McNicoll,
and
J.Labrecque
(2003).
Natriuretic peptide receptor A activation stabilizes a membrane-distal dimer interface.
|
| |
J Biol Chem,
278,
11159-11166.
|
 |
|
|
|
|
 |
B.Bernat,
G.Pal,
M.Sun,
and
A.A.Kossiakoff
(2003).
Determination of the energetics governing the regulatory step in growth hormone-induced receptor homodimerization.
|
| |
Proc Natl Acad Sci U S A,
100,
952-957.
|
 |
|
|
|
|
 |
S.T.Walsh,
L.M.Jevitts,
J.E.Sylvester,
and
A.A.Kossiakoff
(2003).
Site2 binding energetics of the regulatory step of growth hormone-induced receptor homodimerization.
|
| |
Protein Sci,
12,
1960-1970.
|
 |
|
|
|
|
 |
J.N.Varghese,
R.L.Moritz,
M.Z.Lou,
A.Van Donkelaar,
H.Ji,
N.Ivancic,
K.M.Branson,
N.E.Hall,
and
R.J.Simpson
(2002).
Structure of the extracellular domains of the human interleukin-6 receptor alpha -chain.
|
| |
Proc Natl Acad Sci U S A,
99,
15959-15964.
|
 |
|
PDB codes:
|
 |
|
|
|
|
|
 |
P.A.Van Doorn,
and
M.P.Garssen
(2002).
Treatment of immune neuropathies.
|
| |
Curr Opin Neurol,
15,
623-631.
|
 |
|
|
|
|
 |
V.Goffin,
N.Binart,
P.Touraine,
and
P.A.Kelly
(2002).
Prolactin: the new biology of an old hormone.
|
| |
Annu Rev Physiol,
64,
47-67.
|
 |
|
|
|
|
 |
Y.Sandowski,
N.Raver,
E.E.Gussakovsky,
S.Shochat,
O.Dym,
O.Livnah,
M.Rubinstein,
R.Krishna,
and
A.Gertler
(2002).
Subcloning, expression, purification, and characterization of recombinant human leptin-binding domain.
|
| |
J Biol Chem,
277,
46304-46309.
|
 |
|
|
|
|
 |
H.P.Hartung,
B.C.Kieseier,
and
R.Kiefer
(2001).
Progress in Guillain-Barré syndrome.
|
| |
Curr Opin Neurol,
14,
597-604.
|
 |
|
|
|
|
 |
M.Randal,
and
A.A.Kossiakoff
(2001).
The structure and activity of a monomeric interferon-gamma:alpha-chain receptor signaling complex.
|
| |
Structure,
9,
155-163.
|
 |
|
PDB code:
|
 |
|
|
 |
 |
|
The most recent references are shown first.
Citation data come partly from CiteXplore and partly
from an automated harvesting procedure. Note that this is likely to be
only a partial list as not all journals are covered by
either method. However, we are continually building up the citation data
so more and more references will be included with time.
Where a reference describes a PDB structure, the PDB
code is
shown on the right.
|
');
}
}
 |
|